Mid-Cap Tech and Healthcare Face Critical Tests: From Delisting Risks to Mega FinancingsGlobal Report·4 hours agoCYCU-10.86%BJDX-9.65%
Megadeals and PIPE Lifelines: Inside the USD 4.3B Wheaton Stream and XCF's War ChestGlobal Report·1 day ago, 04:18 AMAPUS-13.52%SGAPY-0.47%
The Quiet Restructuring of 2026: Survival Tactics from 10 Niche Market PlayersGlobal Report·1 day ago, 04:13 AMCYCU-10.86%ADP+2.97%
Beyond the Mega-Caps: AI Patent Wars, Housing Slowdowns, and the Market's Messy MiddleGlobal Report·2 days ago, 04:13 AMNLST+0.81%HKPD+10.33%
Columbia Financial's USD 1.7B Raise and Timken's Guidance Hike Lead Mid-2026 Strategic ShiftsGlobal Report·Jul 22 at 04:18 AMCLBK-1.18%TKR+0.29%
Navigating the 2026 Market Fractures: The AI Infrastructure Boom Meets the Consumer Credit SqueezeGlobal Report·Jul 21 at 04:13 AMBRNS+0.32%MX-4.11%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·Jul 17 at 07:05 AMLIMN-6.57%RGNX-5.07%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jun 8 at 07:06 AMNOTV0.00%ADTX+2.86%
02:54 ETAre KW, BRNS, AFBI Obtaining Fair Deals for their Shareholders?prnewswire·May 12 at 01:55 AMBRNS+0.32%KW0.00%
Barinthus Biotherapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNSMorningStar·May 11 at 11:20 AMBRNS+0.32%IBB-0.44%
Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate DevelopmentsUnusual Whales·Apr 30 at 06:31 AMBRNS+0.32%XLV+0.70%
